- ICH GCP
- Реестр клинических исследований ЕС
Последние исследования
EudraCT Number: 2004-002836-25 | Sponsor Protocol Number: QGUY/2004/IL 4-13/01 | Start Date: 2004-12-15 | ||||||
Sponsor Name: Aerovance Inc. | ||||||||
Full Title: A Phase IIa Study To Investigate The Effects of AER 001on Antigen Challenge In Atopic Asthmatic Subjects Following Repeated Administration. | ||||||||
Medical condition: Asthma is characterised by an infiltration of the bronchial mucosa with activated T-lymphocytes (T-cells), eosinophils, and to a lessor extent polymorphonuclear leukocytes. | ||||||||
|
||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||
Trial protocol: GB (Completed) | ||||||||
Trial results: (No results available) |
EudraCT Number: 2004-000540-24 | Sponsor Protocol Number: CLAF237A2310 | Start Date: 2004-12-15 | ||||||
Sponsor Name: Novartis Pharma Services AG | ||||||||
Full Title: A multicenter, double-blind, randomized, active controlled study to compare the effect of long term treatment with LAF237 50 mg bid to gliclazide up to 320 mg daily in drug naïve patients with type... | ||||||||
Medical condition: Type II Diabetes | ||||||||
|
||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||
Trial protocol: DK (Completed) IE (Completed) GB (Completed) DE (Completed) IT (Completed) ES (Completed) | ||||||||
Trial results: View results |
EudraCT Number: 2004-002908-15 | Sponsor Protocol Number: B9E-XM-O401 | Start Date: 2004-12-15 | ||||||
Sponsor Name: Carlos Gómez Martín | ||||||||
Full Title: ENSAYO FASE I/II, MULTICENTRICO DE LA COMBINACIÓN DE CARBOPLATINO Y GEMCITABINA EN EL TRATAMIENTO DE PACIENTES CON CARCINOMA DE OVARIO EN 1ª RECIDIVA TRAS QUIMIOTERAPIA SENSIBLES A PLATINO | ||||||||
Medical condition: Carcinoma de ovario en primera recidiva tras quimioterapia sensible a platino | ||||||||
|
||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||
Trial protocol: ES (Ongoing) | ||||||||
Trial results: (No results available) |
EudraCT Number: 2004-000089-11 | Sponsor Protocol Number: AX-CL-09 | Start Date: 2004-12-15 | ||||||
Sponsor Name: Axonyx Inc | ||||||||
Full Title: A randomised, double-blind, placebo-controlled study to evaluate the safety and efficacy of two different doses of phenserine-tartrate in patients with probable mild to moderate Alzheimer’s disease | ||||||||
Medical condition: Alzheimer's Disease is caused by a loss of nerve cells in the brain, particularly in the areas associated with memory and learning. The onset of Alzheimer's also affects the levels of a certain neu... | ||||||||
|
||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||
Trial protocol: HU (Completed) AT (Completed) | ||||||||
Trial results: (No results available) |
EudraCT Number: 2004-000333-10 | Sponsor Protocol Number: GEN/231/51/BMcK/JCL | Start Date: 2004-12-15 | ||||||
Sponsor Name: Research & Innovation Services, University of Dundee | ||||||||
Full Title: The inhibitory effect of local anaesthetics on the G-protein-mediated vascular flare response to bradykinin and substance P | ||||||||
Medical condition: Healthy volunteers | ||||||||
|
||||||||
Population Age: Adults | Gender: Male | |||||||
Trial protocol: GB (Completed) | ||||||||
Trial results: View results |
EudraCT Number: 2004-000304-41 | Sponsor Protocol Number: FG-506E-12-03 | Start Date: 2004-12-15 | |||||||||||
Sponsor Name: Astellas Pharma GmbH | |||||||||||||
Full Title: A MULTICENTRE, 1:1 RANDOMISED, DOUBLE BLIND, TWO ARM PARALLEL GROUP STUDY TO EVALUATE AND COMPARE THE EFFICACY AND SAFETY OF MODIFIED RELEASE TACROLIMUS FK506E (MR4) VERSUS TACROLIMUS FK506 IN COMB... | |||||||||||||
Medical condition: Patients with end stage kidney disease who will undergo renal transplantation | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) SE (Completed) HU (Completed) FI (Completed) AT (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-002569-19 | Sponsor Protocol Number: Final version | Start Date: 2004-12-15 | ||||||
Sponsor Name: Department of Asthma, Allergy and Respiratory Science, GKT School of Medicine, King's College London | ||||||||
Full Title: The effects of systemic vitamin D administration on production of interleukin-10 by peripheral blood T cells in asthmatics and controls. | ||||||||
Medical condition: This trial is being conducted to test the hypothesis that short-term systemic administration of calcitriol in standard therapeutic dosages increases interleukin-10 production by peripheral blood T-... | ||||||||
|
||||||||
Population Age: Adults | Gender: Male, Female | |||||||
Trial protocol: GB (Completed) | ||||||||
Trial results: View results |
EudraCT Number: 2004-000669-36 | Sponsor Protocol Number: MPR | Start Date: 2004-12-15 | ||||||
Sponsor Name: AZIENDA SANITARIA OSPEDALIERA "S. GIOVANNI BATTISTA DI TORINO" | ||||||||
Full Title: A MULTICENTER, OPEN LABEL STUDY OF ORAL MELPHALAN, PREDNISONE AND CC-5013 (REVLIMID) (MPR) AS INDUCTION THERAPY IN ELDERLY NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS. | ||||||||
Medical condition: NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS. | ||||||||
|
||||||||
Population Age: Elderly | Gender: Male, Female | |||||||
Trial protocol: IT (Ongoing) | ||||||||
Trial results: (No results available) |
EudraCT Number: 2004-001644-80 | Sponsor Protocol Number: FG-506-06-41 | Start Date: 2004-12-15 | |||||||||||
Sponsor Name: Fujisawa GmbH | |||||||||||||
Full Title: Clinical study on tacrolimus ointment over the long-term “Control Study - Children” Revised version of FG-506-06-39 | |||||||||||||
Medical condition: Atopic Dermatitis | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-002700-16 | Sponsor Protocol Number: R096769-PRE-3001 | Start Date: 2004-12-14 | ||||||
Sponsor Name: Janssen-Cilag International N.V. | ||||||||
Full Title: A Placebo-Controlled, Double-Blind, Randomized, Parallel-Group Study of the Efficacy and Safety of Dapoxetine in the Treatment of Subjects With Premature Ejaculation | ||||||||
Medical condition: Premature Ejaculation (PE) | ||||||||
|
||||||||
Population Age: Adults, Elderly | Gender: Male | |||||||
Trial protocol: CZ (Completed) FI (Completed) HU (Completed) GB (Completed) SE (Completed) DE (Completed) AT (Completed) ES (Completed) IT (Prematurely Ended) | ||||||||
Trial results: View results |